Unforeseen ethical challenges for isotretinoin treatment in transgender patients

[1]  K. Katz.  Transgender Patients, Isotretinoin, and US Food and Drug Administration-Mandated Risk Evaluation and Mitigation Strategies: A Prescription for Inclusion. , 2016, JAMA dermatology.

[2]  J. Safer,et al.  Evidence supporting the biologic nature of gender identity. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[3]  K. Baumstarck,et al.  Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. , 2012, The journal of sexual medicine.

[4]  V. Montori,et al.  Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. , 2009, The Journal of clinical endocrinology and metabolism.